Xcovery, LLC. (xcovery)

Oncology Corporate Profile

HQ Location

505 S. Flagler Drive, Suite 1330
West Palm Beach, FL 33401

Company Description

Xcovery is a clinical-stage company focused on the development of next-generation targeted therapeutics for cancer. Founded by Sheridan G. Snyder and Chris Liang, Ph.D., Xcovery’s vision is to successfully develop innovative oncology therapies to optimize patient outcomes. Through innovative drug design, Xcovery has developed a comprehensive pipeline of oncology therapies that target a wide range of advanced tumors.

Website: http://www.xcovery.com

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
X-396ALK inhibitorNon Small Cell Lung Cancer (NSCLC)III
X-396ALK inhibitorVarious cancer typesI
X-82VEGFR/PDGFR inhibitorVarious cancer typesI

View additional information on product candidates here »

Pipeline image

Source


http://www.xcovery.com

Recent News Headlines

There are no news items to display